The Union Health Ministry is planning to roll out capacity building activities for frontline workers involved in ...

NEW YORK, NY / ACCESS Newswire / April 4, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...

NEW YORK, NY / ACCESS Newswire / April 3, 2025 / If you suffered a loss on your Merck & Co., Inc. (NYSE:MRK) investment and want to learn ...

Merck's revenues are driven by cancer med Keytruda, which faces patent expiry by 2028. See why I rate MRK stock a hold.

On February 4, 2025, before the market opened, Merck filed a current report on Form 8-K with the SEC. In the current report, Merck announced their fourth-quarter and full-year 2024 financial results, ...

Cervical cancer is one of the most preventable cancers, although recent research suggests that the United States is ...

up 10.2% year-on-year but down 4.2% quarter-on-quarter due to a decline in demand for the Gardasil franchise, a human papillomavirus [HPV] vaccine. However, I want to point out that thanks to ...

And so, we left the clinic without getting the HPV vaccine, also called Gardasil. Though over 10 years ... in comparison to the national rate of 61.4%. Tens of thousands of eligible Iowa ...

Gardasil 9 is the only HPV vaccine used in the U.S., and it’s also one of the only vaccines on the market that actually prevents cancer. That’s because HPV is behind nearly all cervical cancer ...

The three that fell off the list from 2024 are Pfizer’s COVID-19 vaccine and two cancer medications, Opdivo and Gardasil.

CHARLOTTE — A federal judge granted summary judgment in favor of Merck for part of the litigation involving the HPV vaccine, Gardasil. The rest of the case is still going on. 2022: Local women ...